Last reviewed · How we verify
tacrolimus, standard dose
tacrolimus, standard dose is a Small molecule drug developed by Hoffmann-La Roche. It is currently FDA-approved.
At a glance
| Generic name | tacrolimus, standard dose |
|---|---|
| Sponsor | Hoffmann-La Roche |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Tocilizumab in Lung Transplantation (PHASE2)
- Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation (PHASE2)
- US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia (PHASE2)
- Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies (PHASE2)
- Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients (PHASE2)
- Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY) (PHASE4)
- A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) (PHASE3)
- Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- tacrolimus, standard dose CI brief — competitive landscape report
- tacrolimus, standard dose updates RSS · CI watch RSS
- Hoffmann-La Roche portfolio CI
Frequently asked questions about tacrolimus, standard dose
What is tacrolimus, standard dose?
tacrolimus, standard dose is a Small molecule drug developed by Hoffmann-La Roche.
Who makes tacrolimus, standard dose?
tacrolimus, standard dose is developed and marketed by Hoffmann-La Roche (see full Hoffmann-La Roche pipeline at /company/roche).
What development phase is tacrolimus, standard dose in?
tacrolimus, standard dose is FDA-approved (marketed).
Related
- Manufacturer: Hoffmann-La Roche — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing